Status:
COMPLETED
Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Hip Fracture Surgery
Lead Sponsor:
Daiichi Sankyo Co., Ltd.
Conditions:
Venous Thromboembolism
Eligibility:
All Genders
20+ years
Phase:
PHASE3
Brief Summary
The objective of this study is to evaluate the safety and efficacy of DU-176b compared with enoxaparin sodium for the prevention of venous thromboembolism in patients after elective hip fracture surge...
Eligibility Criteria
Inclusion
- Subjects who are scheduled to undergo surgery within 10 days for fracture of inner or outer femoral neck (trochanteric and subtrochanteric)
Exclusion
- Subjects with risks of hemorrhage
- Subjects with thrombolic risks
- Subjects who weigh less than 40 kg
- Subjects who are pregnant or suspect pregnancy, or subjects who want to become pregnant
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2010
Estimated Enrollment :
92 Patients enrolled
Trial Details
Trial ID
NCT01181141
Start Date
October 1 2008
End Date
February 1 2010
Last Update
March 5 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Osaka, Japan